New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
Researchers develop new method for prenatal genetic testing

Researchers develop new method for prenatal genetic testing

byMassachusetts General HospitalCredit: CC0 Public DomainA team of investigators from Massachusetts General Hospital (MGH), Brigham and Women's Hospital (BWH), and the Broad Institute of MIT
OB & GYN January 16,2024
Researchers develop new method for prenatal genetic testing

Researchers develop new method for prenatal genetic testing

byMassachusetts General HospitalCredit: CC0 Public DomainA team of investigators from Massachusetts General Hospital (MGH), Brigham and Women's Hospital (BWH), and the Broad Institute of MIT
OB & GYN January 16,2024
Inflammation levels tied to severity of blood cancer

Inflammation levels tied to severity of blood cancer

byNYU Langone HealthCredit: Unsplash/CC0 Public DomainSevere inflammation weakens the body's ability to kill cancerous blood cells in people with acute myeloid leukemia (AML), a new study sh
Oncology January 16,2024
Inflammation levels tied to severity of blood cancer

Inflammation levels tied to severity of blood cancer

byNYU Langone HealthCredit: Unsplash/CC0 Public DomainSevere inflammation weakens the body's ability to kill cancerous blood cells in people with acute myeloid leukemia (AML), a new study sh
Oncology January 16,2024
Study finds low anti-Ro titers are not associated with fetal heart block

Study finds low anti-Ro titers are not associated with fetal heart block

byAmerican College of RheumatologyCredit: CC0 Public DomainNew researchfrom an ongoing study that will be presented atACR Convergence 2023, the American College of Rheumatology's
OB & GYN January 16,2024
Study finds low anti-Ro titers are not associated with fetal heart block

Study finds low anti-Ro titers are not associated with fetal heart block

byAmerican College of RheumatologyCredit: CC0 Public DomainNew researchfrom an ongoing study that will be presented atACR Convergence 2023, the American College of Rheumatology's
OB & GYN January 16,2024
Large-scale study finds increased risk of stillbirth following infection with COVID-19

Large-scale study finds increased risk of stillbirth following infection with COVID-19

byUniversity of CopenhagenCredit: Negative Space from PexelsA large-scale Nordic study reveals that women infected with COVID-19 during pregnancy had increased risk of stillbirth. The risk was h
OB & GYN January 16,2024
Large-scale study finds increased risk of stillbirth following infection with COVID-19

Large-scale study finds increased risk of stillbirth following infection with COVID-19

byUniversity of CopenhagenCredit: Negative Space from PexelsA large-scale Nordic study reveals that women infected with COVID-19 during pregnancy had increased risk of stillbirth. The risk was h
OB & GYN January 16,2024
Study: Cancer database's cases dropped 14% in pandemic's first year, indicating 200,000 'missing cases'

Study: Cancer database's cases dropped 14% in pandemic's first year, indicating 200,000 'missing cases'

by Lisa Aubry, Loma Linda University Adventist Health Sciences CenterCredit:JAMA Surgery(2023). DOI: 10.1001/jamasurg.2023.0652Researchers say newly reported cases of cancer diagnoses decl
Oncology January 16,2024
Study: Cancer database's cases dropped 14% in pandemic's first year, indicating 200,000 'missing cases'

Study: Cancer database's cases dropped 14% in pandemic's first year, indicating 200,000 'missing cases'

by Lisa Aubry, Loma Linda University Adventist Health Sciences CenterCredit:JAMA Surgery(2023). DOI: 10.1001/jamasurg.2023.0652Researchers say newly reported cases of cancer diagnoses decl
Oncology January 16,2024
Q&A: Understanding carrier screening for family planning

Q&A: Understanding carrier screening for family planning

by Abby Ashbacher, Mayo Clinic News NetworkCredit: CC0 Public DomainDear Mayo Clinic: My husband and I want to expand our family and are trying to get pregnant with our first baby. I've read about
Q & A January 16,2024
Q&A: Understanding carrier screening for family planning

Q&A: Understanding carrier screening for family planning

by Abby Ashbacher, Mayo Clinic News NetworkCredit: CC0 Public DomainDear Mayo Clinic: My husband and I want to expand our family and are trying to get pregnant with our first baby. I've read about
Q & A January 16,2024
Study shows many expensive cancer drugs have unclear patient benefit

Study shows many expensive cancer drugs have unclear patient benefit

byUniversity of GothenburgDiseases targeted in the included trials. Credit:Clinical Drug Investigation(2023). DOI: 10.1007/s40261-023-01285-4New cancer drugs are being launched rapid
Oncology January 16,2024
Study shows many expensive cancer drugs have unclear patient benefit

Study shows many expensive cancer drugs have unclear patient benefit

byUniversity of GothenburgDiseases targeted in the included trials. Credit:Clinical Drug Investigation(2023). DOI: 10.1007/s40261-023-01285-4New cancer drugs are being launched rapid
Oncology January 16,2024
Four women have two-in-one surgery to reduce their risk of ovarian cancer

Four women have two-in-one surgery to reduce their risk of ovarian cancer

byUniversity College LondonCredit: CC0 Public DomainFour women have successfully had a combined surgery, in which they gave birth by cesarean section and at the same time had surgery to reduce t
OB & GYN January 16,2024
Four women have two-in-one surgery to reduce their risk of ovarian cancer

Four women have two-in-one surgery to reduce their risk of ovarian cancer

byUniversity College LondonCredit: CC0 Public DomainFour women have successfully had a combined surgery, in which they gave birth by cesarean section and at the same time had surgery to reduce t
OB & GYN January 16,2024
Researchers root US maternal health disparities in the social environment

Researchers root US maternal health disparities in the social environment

by Andy Flick,Vanderbilt UniversityCredit: SHVETS production from PexelsMonica Keith, assistant professor of Anthropology, recently published insights into the complex factors contributing to ma
OB & GYN January 16,2024
Researchers root US maternal health disparities in the social environment

Researchers root US maternal health disparities in the social environment

by Andy Flick,Vanderbilt UniversityCredit: SHVETS production from PexelsMonica Keith, assistant professor of Anthropology, recently published insights into the complex factors contributing to ma
OB & GYN January 16,2024
Study shows multiple beams, intervals in delivery decrease the skin-saving benefits of FLASH radiotherapy for cancer

Study shows multiple beams, intervals in delivery decrease the skin-saving benefits of FLASH radiotherapy for cancer

by Katie Pence,University of CincinnatiCredit: CC0 Public DomainA published study by researchers at the University of Cincinnati Cancer Center and Cincinnati Children's Hospital Medical Cent
Oncology January 16,2024
Study shows multiple beams, intervals in delivery decrease the skin-saving benefits of FLASH radiotherapy for cancer

Study shows multiple beams, intervals in delivery decrease the skin-saving benefits of FLASH radiotherapy for cancer

by Katie Pence,University of CincinnatiCredit: CC0 Public DomainA published study by researchers at the University of Cincinnati Cancer Center and Cincinnati Children's Hospital Medical Cent
Oncology January 16,2024
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com